Specialist pharmacy services must be put in place for patients with IBD
The views expressed in this letter are those of the author’s. If you would like to submit a letter to The Pharmaceutical Journal, please click here. An article published by The Pharmaceutical Journal in April 2021 states correctly that, of the nearly 200 inflammatory bowel disease (I…
